Several aromatic aldehydes such as 3-(4-tert-butylphenyl)-2-methylpropanal were shown to adversely affect the reproductive system in male rats following oral gavage dose of ! 25 mg/kg bw/d. It was hypothesized that these aldehydes are metabolized to benzoic acids such as p-tert-butylbenzoic acid as key toxic principle and that Coenzyme A (CoA) conjugates may be formed from such acids. Here we performed a detailed structure activity relationship study on the formation of benzoic acids from p-alkyl-phenylpropanals and related chemicals in rat hepatocytes in suspension. Formation of CoA conjugates from either p-alkyl-phenylpropanals directly or from their benzoic acid metabolites was further assessed in plated rat hepatocytes using high resolution LC-MS. All of the test chemicals causing reproductive adverse effects in male rats formed p-alkyl-benzoic acids in rat hepatocytes in suspension. Compounds metabolized to p-alkyl-benzoic acids led to accumulation of p-alkyl-benzoyl-CoA conjugates at high and steady levels in plated rat hepatocytes, whereas CoA conjugates of most other xenobiotic acids were only transiently detected in this in vitro system. The correlation between this metabolic fate and the toxic outcome may indicate that accumulation of the alkyl-benzoylCoA conjugates in testicular cells could impair male reproduction by adversely affecting CoA-dependent processes required for spermatogenesis. This hypothesis prompted a search for new p-alkyl-phenylpropanal derivatives which do not form benzoic acid metabolites and the corresponding CoA conjugates. It was found that such metabolism did not occur with a derivative containing an o-methyl substituent, ie, 3-(4-isobutyl-2-methylphenyl)propanal. This congener preserved the fragrance quality but lacked the male reproductive toxicity in a 28-day rat study, as predicted from its in vitro metabolism.
3-(4-tert-butylphenyl)-2-methylpropanal, also known as BMHCA, is a widely used fragrance aldehyde. In the rat, adverse effects on male reproduction were observed following oral dosing, namely changes in seminiferous tubules and epithelium, diffuse tubular testicular degeneration, reduction in sperm counts, reduction of testes weight and loss of reproductive performance (ECHA, 2016d) . These effects are seen at various treatment durations (5-90 days) with a reproducible LOAEL of 50 mg/kg bw/d. The same adverse effects were observed for 3-(4-tert-butylphenyl)-2-methylpropanoic acid (BMHCA-acid), indicating that the aldehyde function is not required (ECHA, 2016d) . No effects on male reproductive organs and sperm parameters were observed in mice, rabbits, guinea pigs and rhesus monkeys, while male reproductive effects in dogs were found at 200 mg/kg bw/d in some studies (ECHA, 2016d) . The structurally related fragrance aldehydes 3-(4-tert-butylphenyl)-propanal (BHCA) (ECHA, 2016g), 3-(4-isopropylphenyl)-2-methylpropanal (PMHCA) (ECHA, 2016c), 3-(4-isopropylphenyl)-propanal (PHCA) (ECHA, 2016h; RIFM, 2010) , and 3-(4-isobutylphenyl)-2-methylpropanal (iBMHCA) (RIFM, 2010) also adversely affect sperm formation in rats. No adverse effects on sperm formation were noted for 3-(3-tertbutylphenyl)-2-methylpropanal (m-BMHCA) (ECHA, 2016b) and for 3-(3-isopropylphenyl)-3-methylpropanal (m-iP2MHCA) (ECHA, 2016a) (Table 1) .
It was hypothesized that the toxicity of BMHCA and related aldehydes is due to formation of a specific metabolite. p-Tertbutyl-benzoic acid (tBBA) is formed in vitro in rat hepatocytes and suspected to cause the toxic effects based on multiple lines of evidence (ECHA, 2016d) : (1) This metabolite is also found in rat urine (approximately 10% of the dose) after oral dosing with both BMHCA and BHCA (ECHA, 2016d, g ). (2) tBBA itself has similar adverse effects on the male reproductive system: atrophy of the testes after oral administration (LOAEL of 6-8 mg/kg bw/d) (ECHA, 2016e; EU, 2009; Hunter et al., 1965) and after dermal application (LOAEL 60-70 mg/kg bw/d) (Cagen et al., 1989; ECHA, 2016e; EU, 2009) . (iii) Reduced sperm counts and histopathological findings in testes with an oral LOAEL of 15 mg/kg bw/d were reported for p-tert-butyltoluene which is also metabolized to tBBA (ECHA, 2016f) ( Table 1) . (4) The related carboxylic acid pisopropylbenzoic acid also had effects on male reproductive organs, and it was shown to be a metabolite formed from PMHCA specifically in rat hepatocytes (ECHA, 2016c) . Thus, there is a strong evidence that these p-alkyl benzoic acid metabolites play a role in the toxicity on male reproductive organs in the rat. In all the studies reported above, adverse effects on both the liver (eg, fatty degeneration, pale liver, vacuolization with fat droplets) and the kidney (tubular degeneration) were recorded, in general with similar LOAEL as for the reproduction endpoint. These findings indicate that multiple organs are affected by tBBA and its precursors with a similar adverse effect concentration, although little research was done on the biochemical mechanisms involved. McCune et al. (1982) described the inhibition of several Coenzyme A (CoA) dependent processes (gluconeogenesis, lipogenesis and fatty acid oxidation) by tBBA in rat hepatocytes. An increase in medium chain and long chain acylCoenzyme A (acyl-CoA) levels was observed in rat hepatocytes exposed to tBBA. It was hypothesized that this might be due to formation of tBBA-CoA conjugates, although this could not be tested with the unspecific analytical methods used at the time. Simultaneously, levels of CoA and acetyl-CoA were decreased by tBBA (McCune et al., 1982) . Based on these early studies, we hypothesized that indeed the benzoic acid metabolites could be converted to the corresponding CoA conjugate which then may affect different biochemical targets in lipid metabolism. The metabolic pathway for BMHCA is shown in Figure 1 .
Xenobiotic carboxylic acids can enzymatically be converted to xenobiotic-acyl-S-CoA thioesters which are able to covalently modify proteins (Darnell et al., 2015; Lassila et al., 2015; Li et al., 2003) . Alternatively, xenobiotic-CoA conjugates can interfere with endogenous lipid metabolism, eg, by inhibition of b-oxidation or depletion of the CoA pool (Darnell and Weidolf, 2013) . Different non-steroidal anti-inflammatory drugs, most prominently ibuprofen and ibufenac, had been investigated in detail for their ability to form CoA conjugates (Darnell et al., 2015) . Ibufenac led to the highest formation of CoA conjugates and the highest level of covalent binding. It was withdrawn from the market due to cholestatic or hepatocellular drug-induced liver injury, while only rare liver injury is reported for ibuprofen. These 2 drugs are structurally related to the chemicals investigated in this study (Table 1) . Formation of CoA conjugates had historically been investigated by radiolabeled methods. By using high-resolution mass spectrometry linked to liquid chromatography (LC-HRMS) sensitive detection of specific CoA conjugates has now become possible (Darnell et al., 2015) . Formation of CoA conjugates is often investigated in cell-free systems such as liver homogenates, liver microsomes, liver mitochondria or S9 fractions supplemented with adenosine-5 0 -triphosphate (ATP) and free CoA (Darnell et al., 2015; Tracy et al., 1993) . Alternatively, transient CoA-conjugate formation was also detected in freshly isolated rat hepatocytes incubated in suspension assays (Grillo and Lohr, 2009; Li et al., 2002; Olsen et al., 2005) . However, the use of hepatocytes in suspension is limited due to losses of enzymatic activity within short incubation time (<4 h) (Griffin and Houston, 2004 ). Here we thus studied CoA conjugate formation using plated rat hepatocytes as a longer term metabolic system (Griffin and Houston, 2005) and as a surrogate for potential accumulation of CoA conjugates in target tissues (liver, testes).
We present an assessment of structural features required to form alkyl-benzoic acids from fragrance aldehydes in rat hepatocytes. We provide evidence that p-alkyl-benzoyl-CoA conjugates can accumulate to high and steady levels in rat hepatocytes incubated with the test chemicals showing male rat reprotoxicity and present detailed structure activity data. The metabolic tests were applied in the search for new odorants not leading to this metabolic outcome. We demonstrate how a fragrance aldehyde could successfully be developed which lacks this metabolic outcome and male reproductive toxicity in the rat, further strengthening the correlation between this specific metabolic fate and the observed toxicity.
MATERIALS AND METHODS
Chemicals. Chemicals of analytical grade with the highest purity available were selected. Benzoic acid, p-tert-butyltoluene, p-ethylbenzoic acid, p-isopropylbenzoic acid, m-isopropylbenzoic acid, p-tert-butylbenzoic acid (tBBA), m-tert-butylbenzoic acid (m-tBBA), p-tert-butylcyclohexanecarboxylic acid, p-methylbenzoic acid (p-toluic acid), ibufenac, CoA sodium salt hydrate, acetyl CoA sodium salt, benzoyl CoA lithium salt, octanoyl CoA lithium salt hydrate, decanoyl CoA monohydrate, n-heptadecanoyl CoA lithium salt, tris(hydroxymethyl)aminomethane, potassium chloride, magnesium chloride hexahydrate, citric acid monohydrate, hydrochloric acid, sodium hydroxide, ATP disodium salt hydrate, tert-butyl methyl ether (MTBE), (trimethylsilyl)diazomethane solution (2 M in hexane), and acetonitrile were purchased from Sigma-Aldrich (Buchs, Switzerland). Methanol and ammonia solution (25%) was purchased from Merck KGaA (Darmstadt, Germany), ibuprofen from E-Pharma S.P.A. (Trento, Italy), and p-isobutyl-benzoic acid from TCI (Tokyo, Japan). All fragrance materials were obtained from Givaudan SA (Vernier, Switzerland) except for PHCA which was obtained from IFF (Tilburg, Netherlands) and are listed in Table 1 .
Synthesis of reference compounds and novel fragrance aldehydes. 3-(4-isobutyl-2-methylphenyl)propanal (Nympheal) and 4-(4-isobutylphenyl)butanal were synthesized as described previously (Goeke et al., 2014) . 3-(4-isobutylphenyl)propanal (iBHCA) was synthesized as described in Levorse et al. (2011) and m-BMHCA was synthesized as described by Fortineau (2008) . 3-(4-isobutylcyclohex-3-en-1-yl)propanal was prepared from p-isobutylcyclohex-3-ene-1-carbaldehyde (Kanehira and Fujita, 1984) via Wittig-Horner reaction, followed by hydrogenation, reduction and re-oxidation to the aldehyde. BMHCA-acid (3-(4-tert-butylphenyl)-2-methylpropanoic acid) (ie, carboxylic acid metabolite from BMHCA) and other carboxylic acids were synthesized as reference chemicals from the corresponding fragrance aldehydes by Jones oxidation (Reddy et al., 2015) . p-Isobutyl-2-methyl-benzoic acid was also synthesized by Jones oxidation (Reddy et al., 2015) from the corresponding aldehyde which was made as described by Zou et al. (2016) . The coenzyme A conjugate of tBBA-CoA was synthesized as described by Fielding et al. (2007) . BMHCA, BMHCA-acid, and tBBA are all known to cause similar adverse effects on male reproductive organs and on the liver in rats.
Metabolism studies in rat hepatocytes in suspension. Cryopreserved primary hepatocytes from male rats (pool, Sprague-Dawley) for use in suspension, CHRM (Cyropreserved Hepatocytes Recovery Medium), Williams E Medium (WEM; without Phenol Red, L-glutamine and HEPES) and supplements (Cell Maintenance Supplement Pack) were purchased from Gibco (Life Technologies Europe B.V., Zug, Switzerland). Rat hepatocytes were thawed in CHRM, washed and resuspended in supplemented WEM medium (cocktail solution of penicillinstreptomycin, insulin, transferrin, selenium complex, BSA and linoleic acid; GlutaMAX, HEPES and Dexamethasone). Viable cells were counted using trypan blue (Sigma-Aldrich, Buchs, Switzerland) staining. Viability was between 82% and 93%. Closed 10 ml headspace glass vials (BGB Analytik, Bö ckten, Switzerland) were used for the incubations due to evaporation losses observed in initial experiments with BMHCA. Hepatocytes (400 ml; 1 Â 10 6 viable cells/ml) were pre-incubated on a shaker for 5 min at 37 C and 5% CO 2 prior to closing the vials. Test chemicals (final concentration: 100 mM) were added to the vials containing the cell suspensions, the vials were tightly closed and incubated at 37 C on a shaker. For each replicate and time point one vial was used. Controls with the test chemicals in hepatocyte medium without cells were carried out to assess chemical stability. Samples (200 ml) were removed from the vials after 0, 1, and 4 h and stopped with ice cold 1 M HCl (200 ml) containing ibuprofen as internal standard (50 mM). Samples were extracted with 200 ml MTBE, centrifuged (15 000 Â g, 5 min, room temperature (RT), and analyzed by gas chromatography coupled to mass spectrometry (GC-MS). The remaining sample volume (100 ml from each vial was pooled) was used for liquid chromatography coupled to mass spectrometry (LC-MS) analysis of phase II metabolites after purification using solid phase extraction (OASIS HLB mElution plate 30 mm, Waters, Baden-D€ attwil, Switzerland).
Formation of acyl-CoA conjugates in plated rat hepatocytes. Plateable primary male rat hepatocytes (Sprague-Dawley, Grade P pooled cryopreserved hepatocytes, for plated assays), WEM (with Phenol Red, with GlutaMAX, without HEPES) was purchased from Gibco (Life Technologies Europe B.V.) and supplements from Biopredic International (Saint Gré goire, France). Cells were thawed following the supplier's protocol and seeded at a density of 450 000 cells/ml in 0.25 ml seeding medium (WEM supplemented with fetal bovine serum, Dexamethasone, penicillin-streptomycin, insulin, GlutaMAX and HEPES) using 48-well plates which were coated with collagen (Collagen I Rat Protein, Tail; Gibco, Life Technologies Europe B.V.) and incubated for 4-5 h to facilitate attachment. Then, the medium was changed to culturing medium (WEM supplemented with penicillin, streptomycin, insulin, hydrocortisone without serum) to prevent detachment of cells. Test chemicals were dissolved in methanol (80%-90% methanol) and directly added with the culture medium (0.8-0.9% final methanol concentration). For structure-activity studies, final concentration of test chemicals was 50 mM or 5 mM. Cells were incubated for 0.5-22 h in the presence of test chemicals. To stop the reactions, the culture medium was removed and 0.5 M citric acid (pH 2.0; 60 ml) and cold acetonitrile (60 ml) containing 2 mM decanoyl CoA as internal standard were added to each well. The attached cells were removed and disrupted by scraping the well with a pipette tip and by pipetting up and down several times, transferred in 1.5 ml tubes and frozen at À80 C. The cell lysates were defrozen, centrifuged (21 000 Â g, 5 min, RT), and the supernatant was diluted with 1.36 ml Tris-buffer (4 mM) containing KCl (6 mM), MgCl 2 (0.3 mM), and n-heptadecanoyl CoA as internal standard (0.2 mM). Samples were neutralized by addition of NaOH (42 ml of 1 M NaOH) and loaded onto solid phase extraction cartridges (OASIS HLB mElution plate). Columns were washed with 200 ml of ammonium solution (1 M), and samples eluted sequentially with 50 ml acetonitrile and 50 ml water.
Formation of acyl-CoA conjugates in rat liver S9 fractions.
Incubations were performed in 50 mM Tris-HCl buffer at pH 8.5 containing 72 mM KCl, 3.6 mM MgCl 2 , 1 mg/ml rat liver S9 fractions (Gibco, Life Technologies Europe B.V.), 40 mM CoA and 5 mM ATP. Different carboxylic acids were dissolved in acetonitrile at 0.8 mM, and 2.5 ml were added to a final volume of 200 ml incubation mixture (final concentration: 10 mM) to start the reaction. After 30 min the reaction was stopped by adding 40 ml citric acid (0.5 M, pH 2.0) and 60 ml acetonitrile. The samples were purified with SPE as described earlier.
Determination of benzoic acid metabolites by GC-MS. A GC-MS method was used to determine the decrease of the parent chemicals and the formation of phase I metabolites. Derivatisation with trimethylsilyldiazomethane in methanol was applied to detect methyl esters of the acid metabolites. Aldehydes react also with diazomethane yielding a methyl ketone which was used for quantification of the parent chemicals. Ibuprofen (50 mM) derivatized to its corresponding methyl ester was used as internal standard. Samples were analyzed by GC-MS on an HP 6890 coupled to an MSD 5973 (Agilent Technologies, Basel, Schweiz). The GC column used was a BPX5 (SGE Analytical Science), with an inner diameter of 0.22 mm, a length of 12 m and a film thickness of 0.25 mm. The injector temperature was set to 230 C. Samples (1 ml) were injected splitless at constant flow (1 ml/min, carrier gas: helium). The temperature of the column oven was ramped from 35 C (hold for 2 min) with 20 C/min to 240 C, then with 35 C/min to 270 C (hold for 3 min). The MS analysis was performed with electron ionization at 70 eV and a mass range of m/z 25-460. Single ion monitoring was applied for the quantification of the analytes. To quantify the decrease of test chemicals and formation of metabolites, calibration standards with parent chemicals and putative metabolites (carboxylic acids and benzoic acid metabolites; see Figure 2 ) were prepared in incubation medium.
Detection of CoA conjugates by LC-HRMS.
CoA conjugates were analyzed with LC-HRMS on a Dionex UltiMate 3000 RS HPLC system coupled to a Q-Exactive orbitrap mass spectrometer (Thermo Scientific, Reinach, Switzerland) with electrospray ionization in both positive and negative ionization mode. For liquid chromatography separation an Agilent Zorbax 300Extend-C18 column with dimensions 2.1 Â 50 mm and particle size of 3.5 mm with a 2.1 Â 10 mm precolumn of the same material was used. The flow rate was 0.4 ml/min. Eluent A consists of water containing 0.0025% ammonia (pH around 9.8) and eluent B consists of acetonitrile containing 0.0025% ammonia. A linear gradient was run from 95% eluent A (hold for 1 min) to 100% eluent B within 6 min (hold for 1 min), back to 95% eluent A within 0.5 min followed by 1.5 min equilibration time. The injection volume of the sample was 10 ml. The mass resolution of the HR-MS spectra was set to 70 000. The mass accuracy was <5 ppm. Data-dependent high-resolution product ion spectra (HR-MS/ MS) were recorded at a resolution of 17 500. Ion source parameters adjusted were as follows: sheath gas flow (30 arbitrary unit), auxiliary gas flow (10 arbitrary unit), capillary temperature (270 C), and source voltage (4 kV in positive mode, À3 kV in negative mode). Fragmentation was obtained from dissociation in an octopole collision cell using higher energy collision dissociation settings at 35 and 45 (arbitrary unit). The mass scan range was set from 120 to 1800 m/z. Calibration standards were prepared with CoA, acetyl-CoA, benzoyl-CoA, tBBA-CoA, and octanoyl-CoA to determine the concentrations of CoA conjugates. Decanoyl-CoA and heptadecanoyl-CoA were used as internal standards. The limit of detection with this method is 0.005 mM for CoA conjugates.
Repeated dose 28-day oral toxicity study in rats. 3-(4-isobutyl-2-methylphenyl)propanal was tested in a 28-day subchronic toxicity study according to OECD test guideline 407 (OECD, 2008) . The test substance, formulated in corn oil, was administered once daily by oral gavage for 28 days to Wistar rats. One control group and 3 treated groups (50, 150, and 400 mg/kg bw/d) were tested, each consisting of 5 males and 5 females. An extra 5 animals per sex in the control and high dose group were allowed 14 days of recovery. Clinical pathology and macroscopic observation was performed at termination on all organs while organ weights and histopathology was evaluated on a selection of tissues.
RESULTS

Metabolism and Formation of Benzoic Acids in Rat Hepatocytes in Suspension
In vitro metabolism of test chemicals was assessed in cryopreserved primary rat hepatocytes in suspension (Table 2 ). All parent aldehydes tested were no longer detectable or <1% after 1 h incubation (data not shown). Formation of p-alkyl-benzoic acid (p-alkyl-BA; Figure 2 ) was observed for the p-substituted chemicals BMHCA, BMHCA-acid, BHCA, PMHCA, PHCA, iBMHCA, and iBHCA. In addition, similar amounts of m-tBBA were formed from m-BMHCA compared with BMHCA. p-tert-butyltoluene was oxidized at the methyl group resulting also in the formation of tBBA. Thus, several chemicals with reported male rat reprotoxicity are all metabolized to a palkyl-BA derivative in rat suspension hepatocytes. The a-methyl group in the aldehyde side chain of BMHCA, PMHCA, and iBMHCA reduces p-alkyl-BA-formation compared with the simple propanal derivatives BHCA, PHCA and iBHCA. Higher amounts of the corresponding BA-derivatives were detected with the latter chemicals. No BA formation was found with m-iP2MHCA indicating that the methyl group at b-position of the aldehyde side chain is preventing the oxidation/side chain degradation ( Table 2) .
The BA derivative is the suspected toxic metabolite, however it is a minor metabolite for BMHCA, m-BMHCA, and PMHCA (eg, 3.4%-9.3% tBBA for BMHCA in different lots of hepatocytes) and more abundant for BHCA, PHCA, iBMHCA, and iBHCA (Table 2) . BMHCA-acid was detected as the major phase I metabolite of BMHCA (39%; Figure 2 ; Supplementary Table 1 ). In addition to the oxidation of the aldehydes to the carboxylic acids, reduction and/or hydroxylation followed by glucuronidation or (to a lower extent) formation of acyl-glucuronides are quantitatively more important pathways than BA-formation for the aldehydes tested in rat suspension hepatocytes. The full metabolic map for BMHCA is shown as an example in Supplementary Figure 2 .
Interestingly, 3-(4-isobutyl-cyclohex-3-en-1-yl)propanal was transformed to a BA derivative (p-isobutylbenzoic acid) similarly to BMHCA (4% of parent; Table 2 ). For ibufenac and ibuprofen, no BA formation was detected (data not shown). Only partial turnover in rat hepatocytes in suspension was observed for these 2 chemicals (23%-42% and 8%-26%, respectively).
In further experiments, CoA conjugate formation in cryopreserved rat suspension hepatocytes was investigated. However, we could detect only transient and minor levels of the corresponding BA-CoA conjugates which decreased rapidly after ca. 30 min incubation with the benzoic acids tBBA or p-isobutyl-benzoic acid as test chemicals. Very minor levels of the corresponding xenobiotic-CoA conjugates like tBBA-CoA ( 0.1% of initial aldehyde concentration) were detected with the aldehydes BMHCA or iBHCA which also decreased rapidly (data not shown). Moreover, CoA and acetyl CoA levels decreased rapidly in suspension hepatocytes indicating that the cells do not maintain a steady CoA pool. Thus, this experimental system is not appropriate to study CoA conjugate accumulation for chemicals like BMHCA. Table 2 ) and then further transformed to the corresponding p-alkyl-BAs (Table 1 ) (other phases I and II metabolites are not shown, see Supplementary Figures 2 and 4) . In plated rat hepatocytes, the CoA conjugates of the carboxylic acids were only transiently detected (Supplementary  Table 2 ) and the accumulation of the stable p-alkyl-benzoyl-CoA conjugates (BA-CoAs) was predominant (Table 2) .
CoA Conjugate Formation of BMHCA and tBBA in Plated Rat Hepatocytes Plated rat hepatocytes in monolayer were then further used as a potentially more physiological system. In contrast to hepatocytes in suspension, steady and relatively low levels of CoA and acetyl CoA were detected in plated hepatocytes up to 22 h incubation. BMHCA and tBBA were tested at multiple doses for CoA conjugate formation in plated rat hepatocytes. tBBA was rapidly conjugated to CoA as shown by the LC-HRMS method, and this metabolite rapidly reached a stable plateau at test Rat hepatocyte suspensions were incubated in presence of 100 mM of the test chemical for 4 h and benzoic acid derivatives determined as their methyl-esters by GC-MS. Average concentrations and concentration range from at least 2 independent experiments, each in duplicate are given. All chemicals were tested at 50 mM in plated rat hepatocytes in at least 2 independent experiments each conducted in triplicate. Selected chemicals were also tested at 5 mM and these results are shown in Supplementary Table 2 . CoA conjugates were quantified versus a synthetic sample of tBBA-CoA using LC-HRMS analysis. Data for individual repetitions are expressed as % versus the formation of tBBA-CoA at the given time point from BMHCA tested in all experiments; bd, below detection level.
concentrations !5 mM ( Figure 3A ). The levels of CoA conjugates then remained stable until the end of the incubation (22 h). Interestingly, almost identical results were obtained with BMHCA, which was rapidly metabolized to the tBBA-CoA ( Figure 3B ). In multiple experiments with BMHCA with different hepatocyte lots, 1.5 6 0.5 mM of tBBA-CoA were detected at 22 h (Supplementary Figure 1) . The fresh weight of the cells per well is 2.17 mg, while the volume of the analytical sample is 100 ml. Hence, the actual intracellular concentration of tBBA-CoA is at least 50-fold higher compared with the analytical sample reaching 75 6 25 mM with the assumption of homogenous distribution over all cellular compartments.
Structure Activity Relationship of BA-CoA Conjugate Formation in Plated Rat Hepatocytes
The different chemicals which were transformed to a BAderivative in rat suspension hepatocytes were tested at one concentration (50 mM) in plated primary rat hepatocytes to establish a structure activity relationship (SAR). All data are expressed in % relative to tBBA-CoA-formation from BMHCA at the given time point. This reference was tested in each experiment to normalize for batch-to-batch and experimental variation (see Supplementary Figure 1 ). High and steady levels of BACoA conjugates were detected in incubations with BMHCA, BMHCA-acid, BHCA, PMHCA, PHCA, iBMHCA, iBHCA, and p-tertbutyltoluene (BA-CoA levels in the range of 44%-143% compared with tBBA-CoA from BMHCA; Table 2 ). In general, similar levels of BA-CoA conjugates were detected when these chemicals were tested at a 10-fold lower concentration (5 mM) (Supplementary Table 2 ). Only for iBMHCA these levels were clearly lower at the lower test concentration. Thus, different compounds which are metabolized to p-alkyl-BA all lead to the accumulation of a high and steady concentration of the corresponding CoA conjugate. Interestingly, lower levels of m-tBBACoA were found in incubations with m-BMHCA (18%-33% at a test concentration of 50 mM and 8%-15% at 5 mM), despite the fact that similar amounts of m-tBBA were formed in the suspension assay (Table 2 ). Lower levels of the BA-CoA conjugate were also detected for 3-(4-isobutyl-cyclohex-3-en-1-yl)propanal (14%-22%) although BA formation in hepatocytes in suspension was similar to BMHCA. Only traces of BA-CoA (2%) were found for m-iP2MHCA (Table 2) . To further evaluate the structural requirements for the formation of steady levels of CoA conjugates, we tested different xenobiotic acids in plated rat hepatocytes and quantified the formation of the corresponding CoA conjugates (Table 3) . Negligible amount of benzoyl-CoA (4% of tBBA-CoA from BMHCA) was detected when cells were incubated for 0.5 h with benzoic acid and low amounts of p-methylbenzoyl-CoA (19%) from p-methylbenzoic acid. Both conjugates decreased after 4 h incubation and were not detectable at 22 h. Benzoyl-CoA is known to be rapidly converted into benzoyl-glycine (hippuric acid) as major metabolite of benzoic acid (Badenhorst et al., 2013) . This phase II metabolite was indeed detected in plated rat hepatocytes incubated with benzoic acid (data not shown), whereas no tBBA-glycine conjugate was found with BMHCA or tBBA as test chemicals in plated hepatocytes and only traces in suspension hepatocytes (Supplementary Figure 2) .
On the other hand, high and similar amounts of BA-CoAs were detected with p-ethyl-, p-isopropyl-, and p-isobutylbenzoic acid (39%-87%) which were in the same range or slightly lower compared with tBBA-CoA formed from BMHCA. Thus, accumulation of CoA conjugates occurs for a number of p-alkyl BAs if the alkyl-substituent is at least an ethyl group, while for the methyl analogue only a transient formation of the conjugate is observed. For m-tBBA, we found clearly lower levels of the CoA conjugate (21% for 50 mM and 8% for 5 mM test concentration at 22 h). The CoA conjugate detected with m-isopropylbenzoic acid decreased rapidly after 4 h incubation, which confirms the observation on the impact of the position of the alkyl side-chain on the levels of the corresponding BA-CoAs for m-BMHCA and m-tBBA (Table 3) .
Formation of CoA Conjugates for Acids With Longer Side Chains
BMHCA-acid is the major phase I metabolite of BMHCA in rat hepatocytes in suspension (Supplementary Table 1 ) and thus theoretically this metabolite may lead to even higher levels of CoA conjugates (see Figure 1) . Thus, we analyzed the formation of the BMHCA-acid-CoA conjugate from BMHCA in plated rat hepatocytes. At 0.5 h incubation, around 0.15 mM of this CoA derivative is detected (ie, ca. 12% of the level of tBBA-CoA). However, the level of this CoA conjugate strongly decreased over time (0.1% at 22 h). Similarly, for m-BMHCA, BHCA, PMHCA, PHCA, iBMHCA, and iBHCA, the CoA conjugate of the oxidized aldehyde was transiently formed as minor metabolite at 0.5 h and decreased below the detection level within 22h (Supplementary Table 1 ). Similar amounts of the BMHCA-acidCoA conjugate compared with incubations with BMHCA were found when BMHCA-acid was added directly to the cells (6% at 0.5 h). We compared the fate of these CoA conjugates with the 2 drugs ibuprofen and ibufenac containing a 2-carbon side chain. For both compounds, we observed relatively high levels of the CoA conjugates at 0.5 h (83%-95% compared with tBBA from BMHCA). Ibuprofenyl-CoA decreased dramatically over prolonged incubation (3% at 22 h) similarly to BMHCA-acid-CoA, while the decrease was slower for ibufenacyl-CoA (33% at 22 h) (Table 3) . Thus, formation of steady and high levels of CoA conjugates in plated rat hepatocytes seems to be a specific metabolic hallmark mainly for p-alkyl-BA and their precursors, and, to some extent, for the hepatotoxic ibufenac.
Formation of CoA Conjugates of Unsaturated Acids
In addition to the importance of the length of the acid side chain and the effect of the position of the alkyl-chain, we investigated the impact of the aromatic ring for steady CoA conjugate formation. The saturated analogue p-tert-butylcyclohexanecarboxylic acid was also quite efficiently transformed to the CoA conjugate (51% at 0.5 h compared with tBBA from BMHCA), but this metabolite decreased over time (6% at 22 h) (Table 3) . Only low level of tBBA-CoA formed by aromatization were detected (3%-4% of the amount formed from BMHCA). However, we found the partly unsaturated p-tert-butylcyclohexenyl-CoA as metabolite (18%-35% compared with tBBA from BMHCA). Similar observations were made for the unsaturated 3-(4-isobutyl-cyclohex-3-en-1-yl)propanal, although slightly higher levels of the corresponding BA-CoA were detected (14%-21% of the amount formed from BMHCA) (Supplementary Figure 3 and  Supplementary Table 3) .
We also investigated formation of other CoA conjugates in the plated hepatocyte experiments. In general, amounts of physiological acids conjugated to CoA such as oleoyl-CoA, palmitoyl-CoA, arachidonoyl-CoA were clearly lower (<0.1 mM) as compared with the accumulated BA-CoA conjugates which became the dominant CoA conjugates in the cells.
CoA Conjugate Formation in Rat Liver S9 Fractions
Cell free assays are more convenient and are traditionally used to study CoA conjugation. To further investigate the SAR for CoA conjugation and to compare data from a cell free system to All chemicals were tested at 50 mM in at least 2 independent experiments in triplicate except for BMHC-acid and m-isopropylbenzoic acid (only one experiment).
Selected chemicals were also tested at 5 mM and these results are shown in Supplementary Table 2 . CoA conjugates were quantified versus a synthetic sample of tBBACoA using LC-HRMS analysis. Data for individual repetitions are expressed as % versus the formation of tBBA-CoA at the given time point from BMHCA tested in all experiments as reference; bd, below detection level.
the more physiological plated hepatocytes, different xenobiotic acids were incubated in presence of CoA, ATP and rat liver S9 fractions. The experiment was carried out 4 times using different batches of S9 fractions. Since the enzymatic activity was varying between the different batches, the data are expressed relative to the formation of tBBA-CoA (Figure 4) . In a typical experiment, 2.4 mM of tBBA-CoA was formed with the consumption of 2.5 mM of the substrate (initial concentration 10 mM). Overall, similar observations were made as in plated hepatocytes: the highest concentrations of CoA conjugates were found with p-substituted benzoic acids. Much lower amounts of the corresponding CoA conjugates were detected for benzoic acid and m-isopropylbenzoic acid. Moreover, lower concentrations of CoA conjugates were found with longer chain acids such as ibuprofen, ibufenac and BMHCA-acid. When compared with ibuprofen (0.9% of tBBA), higher amounts of the CoA conjugate for ibufenac (6.8% of tBBA) were detected. However, the levels of the corresponding CoA conjugates are clearly lower compared with the p-alkyl benzoic acids. Interestingly, efficient conjugation is also observed for the saturated analogue p-tert-butylcyclohexanecarboxylic acid (107% of tBBA) (Figure 4 ). Although these results overall confirm the SAR observed in plated hepatocytes, conjugation in rat liver S9 fractions does not fully mimic the observations in plated rat hepatocytes. Not all acids which were efficiently conjugated with CoA in S9 fractions did accumulate substantially in plated hepatocytes after 22 h incubation. On the other hand, p-methylbenzoic acid and p-tert-butylcyclohexanecarboxylic acid do form high levels of CoA conjugates in S9 fractions, but only transiently form the conjugates in plated rat hepatocytes, while the CoA conjugate formation for the hepatotoxic ibufenac observed over time in hepatocytes would be underestimated if only tested in S9 fractions.
Application to the Design of Novel Molecules
The understanding on the metabolic fate of BMHCA and related molecules was applied to the screening for new candidate fragrance chemicals devoid of male reprotoxicity in rat. In a first tier, novel molecules were screened for the lack of benzoic acid formation. One approach was to design molecules lacking the aromatic ring. However, the cyclohexene derivative 3-(4-isobutylcyclohex-3-en-1-yl)propanal did still lead to benzoic acid formation due to side chain degradation and aromatization in the suspension assay and was further transformed to the corresponding CoA conjugate (p-isobutylbenzoyl-CoA) in plated hepatocytes (Table 2, Supplementary Figure 3 and Supplementary  Table 3B ). Another approach was the introduction of a methylbranching at the b-position instead of the a-position in the side chain (similar to m-iP2MHCA). The b-substituted 3-(4-isobutylphenyl)-3-methylpropanal was not metabolized to the corresponding benzoic acid (Table 2) . However, it lacked the desired odor qualities. Most surprisingly, benzoic acid formation could be fully blocked by alkylation at the ortho-position next to the aldehyde side chain. Thus, 3-(4-isobutyl-2-methylphenyl)propanal (Nympheal) ( Table 2 ) and similar o-methyl derivatives (Goeke et al., 2014) were not metabolized to the corresponding BA-derivatives. To verify this analytical result, the putative BA metabolite p-isobutyl-2-methylbenzoic acid was synthesized as reference standard. The full metabolic map for 3-(4-isobutyl-2-methylphenyl)propanal is shown in Supplementary Figure 4 .
This lead candidate was further tested in plated rat hepatocytes. As for BHMCA, direct oxidation of the aldehyde to the acid (ie, 3-(4-isobutyl-2-methylphenyl)propanoic acid) with formation of the corresponding CoA conjugate was observed within 0.5 h (Supplementary Table 1 ). As for BMHCA-acid, this CoA conjugate was detected at low levels and declined over the 22 h incubation. However, p-isobutyl-2-methylbenzoyl-CoA was below detection limit in all experiments (n ¼ 4), indicating that BA formation and subsequent CoA conjugation is not detectable for this ortho-methylated analogue (Table 2) .
3-(4-Isobutyl-2-Methylphenyl) Propanal Tested in a 28-Day Oral Toxicity Study in Rats
Based on these promising in vitro results and a high perfumistic appeal, the lead compound was submitted to the full range of toxicological testing, including a 28-day oral gavage study in rat with full histopathological examination at study termination. Dose levels up to 500 mg/kg of the test chemical were well tolerated by males and females. No mortality occurred and no clinical signs of toxicity were noted. There were no test chemical-related histologic changes on the testes, seminal vesicles and the epidymides observed up to the maximal dose (LOAEL > 500 mg/kg bw/d). Adverse effects on the liver (hepatocellular hypertrophy) and on the kidney in males (increased incidence and severity of hyaline droplet accumulation likely representing a 2u -globulin, a male rat specific protein) occurred only at the maximal test concentration (LOAEL of 500 mg/kg). This indicates that not only the adverse effects on testes and spermatogenesis observed for BMHCA are abolished by blocking the metabolism to the benzoic acid and the benzoyl-CoA conjugate, but that toxic effects on other organs are substantially reduced compared with BMHCA. This may indicate that all toxic endpoints observed for BMHCA and BMHCA-related materials in multiple studies in the rat are related to the benzoyl-CoAdependent mechanisms and therefore drastically reduced by blocking this metabolic step. No reproductive toxicity studies of longer duration were conducted, as the adverse effects of BMHCA and related aldehydes on male reproductive tissues were always evident in studies conducted for 28 days or even shorter duration.
DISCUSSION p-Alkyl Benzoic Acids as Common Metabolites for Some Male Rat Reprotoxicants
The data from the suspension hepatocyte experiments clearly indicate that the chemicals in Table 1 with male reprotoxic effects in the rat are metabolized to p-alkyl benzoic acids, supporting the hypothesis that these are the primary toxic metabolites. It is not fully clear which enzymes are involved in benzoic acid formation, but one possibility is that the aldehydes are oxidized to the corresponding acids, conjugated to CoA and then undergo b-oxidation to form the corresponding alkyl benzoic acid metabolite. This would explain why ibufenac with a 2-carbon side chain is not efficiently transformed. On the other hand, p-alkyl-4-phenylbutanals can be transformed to an alkyl benzoic acid metabolite (Goeke et al., 2016) , albeit at ca. 15-fold lower levels as compared with the similar p-alkyl-3-phenylpropanals investigated here. This finding indicates that b-oxidation is the main but probably not the sole pathway for formation of the BA metabolite. BHCA is more rapidly metabolized than BMHCA indicating that this transformation is slowed down by a-methyl substitution in the side chain. The p-alkyl benzoic acids are only minor metabolites (ie, around 6% for BMHCA and up to 19% for BHCA) in rat hepatocytes in suspension. In contrast, p-alkyl benzoic acids were found as main urinary metabolites in both animal studies (ECHA, 2016d) and in humans following oral dosing (Scherer et al., 2017) , thus the suspension assay may only partly reflect the in vivo situation. Oxidation and reduction of the aldehyde, CYP mediated hydroxylation and glucuronidation seem to be the major pathways in suspension assays (Supplementary Figure 2) , whereas these pathways may be less predominant in vivo. The rapid formation of the p-alkylbenzoic acids and their CoA conjugates in plated rat hepatocytes may indicate that, as compared with suspension cells, a more physiological system for this metabolic pathway is needed which facilitates biochemical reactions such as b-oxidation and provides the ATP necessary for CoA-conjugation, which in turn requires fully active mitochondria. (Table 1) . Interestingly, similar amounts of m-tBBA were formed with m-BMHCA in rat hepatocytes in suspension compared with the para-substituted BMHCA, but only limited CoA conjugate formation was observed which correlates with a lack of male reprotoxic effects observed in vivo. Similarly, meta-substituted benzoic acids formed lower levels of CoA conjugates in liver S9 fractions and at 22 h in plated hepatocytes, confirming this position effect.
The data from this study indicate a common metabolic fate for the investigated group of toxicants in hepatocytes, which is one of the target organs. Furthermore it shows that closely related chemicals for which this metabolic fate is reduced or absent (m-BMHCA, m-iP2MHCA, 3-(4-isobutyl-2-methylphenyl)propanal) also lack testicular toxicity. Nevertheless, the conclusions are so far based on correlation. It will be important to test in further studies whether these CoA conjugates can also be formed in vivo and whether they are formed in the testicular tissue.
CoA conjugate formation was often investigated in cell-free systems which is highly dependent on the added concentrations of ATP and CoA. Our data indicate that plated cryopreserved primary rat hepatocytes are an interesting alternative tool to monitor CoA-conjugate formation and in particular accumulation over prolonged incubation periods at physiological endogenous ATP and CoA concentrations.
Potential Molecular Targets of p-alkyl-BA-CoA Conjugates If the CoA conjugates are in fact involved in testicular toxicity, the question arises on the potential molecular mode of action of adverse effects on the testis. In case the CoA conjugate becomes a predominant form of CoA in the reproductive tissue as observed in hepatocytes, it is possible that an enzymatic process dependent on CoA or its conjugates (eg, metabolism of specific lipids, synthesis of fatty acids) is competitively inhibited. To address that question, further in vivo studies on this group of chemicals may include lipid and CoA conjugate profiling of testes of treated rats. The ability of BMHCA to bind to estrogen receptors, to stimulate estrogen-responsive gene expression and to increase proliferation of estrogen dependent MCF7 cells had been investigated (Charles and Darbre, 2009) . Although estrogenic activity was described for BMHCA in vitro, the active concentrations were ca. 3 000 000-fold higher and the responses lower compared with 17b-estradiol (Charles and Darbre, 2009 ). The biochemical mode of action proposed here would indicate that the observed reprotoxic effects are not due to direct effects on the estrogen receptor.
Threshold Effect
Competitive inhibiton of cellular processes requiring CoA is hypothesized here as a biochemical mode of action of BMHCA and tBBA. Some level of accumulation of CoA conjugates as suspected toxicants would be required to adversely affect the target tissue. For BMHCA and tBBA, we found significant accumulation starting at the 1 mM dose added to the culture medium. At a dose not sufficient for accumulation of CoA conjugates in the target tissue, no competitive biochemical effects would be expected. Thus, the proposed biochemical mode of action of these toxicants is expected to have a clear threshold for toxicity. This interpretation is supported by the collected in vivo evidence. For the chemicals summarized in Table 1 , LOAEL values are in a relatively narrow range. Furthermore, several studies on BMHCA of different time durations all found a NOAEL of 25 and a LOAEL of 50 mg/kg bw/d (ECHA, 2016d), indicating a reproducible toxicological threshold. This may be of importance for the safety assessment of such chemicals. Based on a limited biomonitoring study (Scherer et al., 2017) , a daily intake of BMHCA (and other potential precursors leading to tBBA) of 0.2 mg/individual/day (ie, ca. 0.003 mg/kg bw/d) was estimated, indicating a large margin of safety (8000-fold) versus the NOAEL for male rat toxicity.
Application of the Molecular Mechanism to Identify Nonreprotoxic Derivatives
Despite the threshold considerations discussed above which may allow to determine acceptable use levels for risk assessment, the reprotoxicity labelling of a number of fragrance aldehydes is prohibitive for many cosmetic manufacturers and applications. Thus, we applied the in vitro tests in a screening program, testing novel derivatives for the formation of the corresponding alkylbenzoic acids in rat hepatocytes in suspension and CoA conjugate formation in plated rat hepatocytes. The most surprising and promising molecular property able to block formation of these benzoic acid derivatives was alkylation at the ortho-position in the benzyl ring. Thus, no detectable levels of the p-alkylbenzoic acid metabolite were formed with 3-(4-isobutyl-2-methylphenyl)propanal, while the desired odor properties were maintained. The data from the plated hepatocyte assay confirmed this finding with no accumulation of CoA conjugates observed (Table 2) . More importantly, when this compound was tested in a 28-days repeat dose study as required for chemical registration, no adverse effects on male reproductive organs and sperm parameters were observed up to the maximal test dose. This confirms the correlation between the formation of p-alkylbenzoic acids and their CoA conjugates and the toxicity of the molecules described in this study. Furthermore, it highlights the importance of understanding these initial events to design and screen for safer chemicals. This novel aldehyde was recently introduced to the market under the trade name Nympheal as a potential alternative for materials such as BMHCA.
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